相关实验视频

Updated: Jun 28, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

收养T细胞疗法用于卵巢癌

Sarah B Gitto¹, Chibuike J N Ihewulezi¹, Daniel J Powell²

¹Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Gynecologic oncology

|April 11, 2024

概括

收养细胞疗法 (ACT) 为卵巢癌治疗提供了一个有希望的替代方案,特别是当标准疗法失败时. 这种方法利用患者的免疫系统,特别是T细胞,有效地准和消除瘤.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

尽管使用化疗等标准治疗方法,但卵巢癌经常复发.
卵巢癌是免疫的,瘤透淋巴细胞 (TILs) 与更好的结果相关.
采用细胞疗法 (ACT) 利用免疫系统进行癌症治疗.

研究的目的:

审查目前对卵巢癌的ACT策略.
为促进卵巢癌治疗的ACT提供见解.
探索利用T细胞用于卵巢癌免疫疗法.

主要方法:

对卵巢癌现有的ACT协议的审查.
讨论T细胞生成方法:树突细胞疫苗,瘤透性淋巴细胞 (TILs) 和转基因T细胞 (TCR,CAR).
从周围血液或瘤微环境中获取T细胞的分析.

主要成果:

有多种途径可以为ACT生成瘤特异性T细胞产物.
TILs提供患者特定的癌症识别.
基因工程T细胞 (TCR,CAR) 可以针对特定的瘤抗原.

结论:

ACT是一种可行的,有前途的卵巢癌治疗策略.
在ACT协议的进一步进步对于改善患者的治疗结果至关重要.
利用T细胞介导免疫力是克服卵巢癌复发的关键.

关键词:

收养细胞疗法采用细胞疗法.在CAR T细胞中.癌症疫苗疫苗癌症疫苗卵巢癌是发生在卵巢中的癌症.在T细胞,T细胞.在TCR中,可以使用TCR.这就是TILs.

更多相关视频

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...